Evolent Health (EVH) IPO Opens at $18; Priced 11.5M Common at $17/Share

Evolent Health, Inc. (NYSE: EVH) opened for trading at $18 after pricing 11.5 million shares of its Common Stock at $17 per share

The underwriters have been granted an option to purchase up to 1,725,000 additional shares of Class A common stock from Evolent at the initial public offering price, less underwriting discounts and commissions. Evolent's Class A common stock has been approved for listing on the New York Stock Exchange under the symbol "EVH", subject to official notice of issuance.

J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint bookrunners for the offering. Wells Fargo Securities, LLC, William Blair & Company, L.L.C., SunTrust Robinson Humphrey, Inc. and Leerink Partners LLC are acting as co-managers.

You May Also Be Interested In

• SK Hynix's Solidigm eyes 2027 IPO at value up to $150 billion - Reuters
• Wells Fargo Starts Forgent Power Solutions (FPS) at Equal Weight
• Accelevation launches IPO roadshow, targets Nasdaq listing